Pikkelysömör: vizsgálatok itt: Románia
4 trials · From ClinicalTrials.gov, checked 2026. november 11.. Ask the study team whether a trial fits you.
- No phaseTaking peopleA Study of Persistence to Guselkumab Treatment in Participants With Moderate-to-Severe Plaque Psoriasis in Romania
- Where
- Bârlad, Brasov, Bucharest, Cluj-Napoca, Constanța, Craiova, Iași, Oradea, Reghin, Slatina, Suceava, Târgu-Mures, Timișoara
- Életkor
- 18 év and over
- People
- 200
- Run by
- Janssen Research & Development, LLC
See details and how to joinNCT07582783 - 3. fázisTaking peopleLong-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
- Where
- Brasov, Bucharest, Constanța, Craiova, Iasi, Iași, Reghin, Timisoara
- Életkor
- 40 év and over
- People
- 3040 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07116967 · EU 2023-503766-24-00 - 3. fázisTaking peopleA Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Bucharest, Cluj-Napoca, Iași, Timișoara
- Életkor
- 12 év to 17 év
- People
- 366 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT06979453 · EU 2023-506296-97-00 - 3. fázisTaking peopleA Study to Evaluate the Drug Levels, Efficacy and Safety of Deucravacitinib in Children and Adolescent Participants With Moderate to Severe Plaque Psoriasis
- Where
- Bucharest, Jassi, Târgu Mureş
- Életkor
- 4 év to 18 év
- People
- 153 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04772079 · EU 2022-502519-13-00